Ono Pharmaceutical Co (MEX:4528N) Asset Turnover: 0.11 (As of Mar. 2026)


MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
88 GF Score
Price MXN341.69
GF Value MXN324.16
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Asset Turnover?

Ono Pharmaceutical Co MEX:4528N 88 Asset Turnover is 0.11 as of Mar. 2026. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Ono Pharmaceutical Co's Revenue for the three months ended in Mar. 2026 was MXN13,495 Mil. Ono Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2026 was MXN125,487 Mil. Therefore, Ono Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2026 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. Ono Pharmaceutical Co's annualized ROE % for the quarter that ended in Mar. 2026 was 0.38%. It is also linked to ROA % through Du Pont Formula. Ono Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2026 was 0.30%.

Ono Pharmaceutical Co  (MEX:4528N) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Ono Pharmaceutical Co's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=371.832/96822.5605
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(371.832 / 53978.54)*(53978.54 / 125487.469)*(125487.469/ 96822.5605)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.69 %*0.4302*1.2961
=ROA %*Equity Multiplier
=0.30 %*1.2961
=0.38 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Ono Pharmaceutical Co's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=371.832/125487.469
=(Net Income / Revenue)*(Revenue / Total Assets)
=(371.832 / 53978.54)*(53978.54 / 125487.469)
=Net Margin %*Asset Turnover
=0.69 %*0.4302
=0.30 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Ono Pharmaceutical Co Asset Turnover Related Terms

Ono Pharmaceutical Co Asset Turnover Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co Asset Turnover Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.50 0.51 0.54 0.43

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.12 0.12 0.13 0.11

MEX:4528N vs LLY, JNJ, ABBV: Asset Turnover Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ono Pharmaceutical Co Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Asset Turnover falls into.


MEX:4528N
88GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Ono Pharmaceutical Co's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=58613.801/( (146040.63+125744.35)/ 2 )
=58613.801/135892.49
=0.43

Ono Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=13494.635/( (125230.588+125744.35)/ 2 )
=13494.635/125487.469
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.11 mean?
Ono Pharmaceutical Co (MEX:4528N) has a Asset Turnover of 0.11 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Ono Pharmaceutical Co and its competitors.
Is Ono Pharmaceutical Co's Asset Turnover too high?
Ono Pharmaceutical Co's current Asset Turnover is 0.11. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Asset Turnover compare to LLY and JNJ?
Ono Pharmaceutical Co's Asset Turnover of 0.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current Asset Turnover is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Asset Turnover of 0.11. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Asset Turnover is 0.11. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Asset Turnover is 0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.

Key valuation signals for MEX:4528N:

  • Asset Turnover: 0.11
  • GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score

Get the complete analysis for MEX:4528N

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN324.16
GF Value